Gloria Duah: Regular Voluntary Blood Donation Remains One of the Most Powerful Acts of Humanity in Healthcare
Gloria Duah, Doctor of Medical Laboratory Science at Komfo Anokye Teaching Hospital, Gender Children and Social Protection Minister of United Nations Youth Association-Ghana (UNYA-GH), shared a post on LinkedIn:
” ‘I donated blood and didn’t use it, so give me back my blood.’
This is one of the common statements we hear from patients and relatives at the transfusion medicine unit.
Some even request that the exact blood they donated be transfused back into them.
Honestly, from their perspective, it sounds reasonable at first.
But blood donation doesn’t work like a personal bank account where you deposit and withdraw anytime you want. In reality, you are very unlikely to receive the exact unit you donated.
Once blood is donated, it goes through several critical processes: screening, grouping, processing, storage, and inventory management.
After that, it becomes part of a lifesaving pool meant to serve whoever urgently needs it first, it could be accident victims, surgical patients, cancer patients, mothers with severe bleeding, and many others.
Blood also has a shelf life. Red cells expire, platelets expire even faster, and some units may no longer remain suitable over time.
The blood bank system is built on availability and replacement, not ‘ownership’.
It is a community support system for healthcare.
Every donation strengthens the system and increases the chances that blood will be available when anyone, including the donor someday, urgently needs it.
That is why regular voluntary blood donation remains one of the most powerful acts of humanity in healthcare.
Healthcare workers in transfusion medicine and related units, what are some misconceptions or experiences you’ve encountered regarding blood donation?”
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?
-
Aug 31, 2026, 14:24Akl Fahed: Do Lifelong Differences in LDL Cholesterol Influence the Risk of Venous Thromboembolism?
-
Aug 31, 2026, 14:23Accelerating CAR-T Access Through Policy and System Reform – American Society of Hematology
-
Aug 31, 2026, 14:21Shirya Rashid: Does Bempedoic Acid Influence Venous Thromboembolism Risk?
-
Aug 31, 2026, 14:14Jason Andrade: SINGLE-AF Trial Validates Early Anticoagulation in AF
-
Aug 31, 2026, 14:12Leonardo Roever: Diagnosis and Management of Natural Anticoagulant Deficiencies
-
Aug 31, 2026, 14:07Ben Dowsing: Can Heart Failure Therapy Be Safely Withdrawn After HER2 Cardiotoxicity Recovery